Tarsus Pharmaceuticals (TARS) Other Working Capital Changes (2019 - 2026)

Tarsus Pharmaceuticals' Other Working Capital Changes history runs 8 years deep, the most recent figure standing at $13.2 million for Q1 2026.

• In Q1 2026, Other Working Capital Changes rose 251.79% year-over-year to $13.2 million; the TTM figure through Mar 2026 stood at $22.0 million (up 378.34% YoY), while the FY2024 annual figure was -$233000.0, down 108.07% from the prior year.
• Other Working Capital Changes was $13.2 million for Q1 2026 at Tarsus Pharmaceuticals, up from $8.7 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $13.2 million in Q1 2026 to a low of -$8.7 million in Q1 2025.
• Historically, Other Working Capital Changes has averaged $1.3 million across 5 years, with a median of $33000.0 in 2023.
• The sharpest annual moves came in 2023 and 2025: Other Working Capital Changes soared 1200.0% in 2023, then tumbled 719.25% in 2025.
• A 5-year view of Other Working Capital Changes shows it stood at $795000.0 in 2022, then soared by 263.9% to $2.9 million in 2023, then slumped by 71.24% to $832000.0 in 2024, then soared by 948.68% to $8.7 million in 2025, then jumped by 51.79% to $13.2 million in 2026.
• The last three Other Working Capital Changes figures came in at $13.2 million (Q1 2026), $8.7 million (Q2 2025), and -$8.7 million (Q1 2025), per Business Quant data.